GlassScriptPhysician profile
Paul Schwartz
NPI 1356379200
$3,160.07
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $672 · 2021: $940 · 2022: $50.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $829.50 | 2019-2021 | |
| Abbvie INC. | $752.42 | 2019-2021 | |
| Pfizer INC. | $427.96 | 2019-2021 | |
| Janssen Biotech, INC. | $247.84 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $148.70 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $108.06 | 2019-2021 | |
| Covidien LP | $106.90 | 2019 | |
| Intercept Pharmaceuticals, INC. | $79.87 | 2019-2021 | |
| Shionogi INC | $74.44 | 2019 | |
| Allergan, INC. | $71.95 | 2019 | |
| Ucb, INC. | $50.40 | 2019 | |
| Qol Medical, LLC | $41.52 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $27.45 | 2019-2020 | |
| Redhill Biopharma INC. | $24.93 | 2020 | |
| Dova Pharmaceuticals | $24.28 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.61 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.64 | 2021 | |
| Gilead Sciences, INC. | $19.28 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.72 | 2021 | |
| Shire North American Group INC | $17.22 | 2019 | |
| Genzyme Corporation | $16.27 | 2022 | |
| Merck Sharp & Dohme LLC | $15.11 | 2019 | |
| Alfasigma USA, INC. | $15.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.